SCHEMBL4178579

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL4178576	1.00	SLC6A2 (0.34)	SLC6A2SLC6A4CYP1A1CYP1B1SLC6A3
	SCHEMBL4171459	0.85	—	—
	SCHEMBL4171454	0.85	—	—
	SCHEMBL4176460	0.82	SLC6A2 (0.30)	SLC6A2SLC6A4
	SCHEMBL4176457	0.82	SLC6A2 (0.30)	SLC6A2SLC6A4
	SCHEMBL612232	0.82	—	—
	SCHEMBL612233	0.82	—	—
	SCHEMBL4170845	0.82	MTNR1A (0.37)	—
	SCHEMBL4170840	0.82	MTNR1A (0.37)	—
	SCHEMBL21941767	0.79	PNMT (0.31)	SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.